InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by EGLINTON MANNER CARRIE. Director active across 4 companies, notably REPLIGEN CORP. Aggregated, 7 filings have been logged. The latest transaction was filed on 4 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€4m814,830 shares@ €4.56611.80% mcap100.0% of flow
Common Stock
SEC:0001062993-22-014386:0·
01,024 shares0
Common Stock
SEC:0000899243-22-020272:0·
€2m16,162 shares@ €119.62820.010% mcap92.5% of flow
Common Stock
SEC:0001022079-22-000056:0·
03,915 shares0
Common Stock
SEC:0001022079-22-000029:0·
€157,0841,368 shares@ €114.82780.0008% mcap7.5% of flow
Common Stock
SEC:0001022079-22-000011:0·
0457 shares0
Common Stock
SEC:0000899243-21-019713·
0457 shares0
Common Stock
SEC:0000899243-21-019713:0·
7 of 7 declarations
About EGLINTON MANNER CARRIE
Carrie Eglinton Manner is a director at Repligen CORP, and she also holds positions at Quest Diagnostics INC and ORASURE TECHNOLOGIES INC.
